Protein-Lipid Complexes in Cancer Cell Death

Protein-lipid complexes, notably those formed between fatty acids and milk-derived proteins, have emerged as selective inducers of cancer cell death. Central to this field are complexes of α-lactalbumin with oleic acid, which adopt molten-globule-like conformations that facilitate membrane binding and internalisation in malignant cells. Once internalised, these assemblies disrupt mitochondrial and plasma membranes, trigger calcium-dependent pathways and engage apoptotic machinery, while sparing healthy cells. Beyond α-lactalbumin, other proteins such as lactoferrin and casein fractions can form antitumour complexes with long-chain fatty acids, broadening the scope of therapeutic candidates. Collectively, these complexes act by modulating membrane integrity, reprogramming cellular metabolism and downregulating proliferative and survival signalling, offering a promising route to targeted cancer therapy with minimal systemic toxicity.

Research from Nature Portfolio

A peroral study in a hereditary colorectal cancer mouse model demonstrated that daily administration of a bovine α-lactalbumin–oleic acid complex in drinking water markedly suppressed intestinal tumour formation and prolonged survival without observable toxicity. Treatment repressed key oncogenic pathways, notably Wnt/β-catenin and PD-1 signalling, and downregulated genes governing angiogenesis, migration and metastasis. Systemic dissemination to lung, liver, spleen and kidney was also inhibited, while metabolic profiling revealed coordinated repression of carbohydrate and lipid metabolism in tumour-prone mice and mild regulation in healthy controls. These findings indicate that sustained delivery of protein-lipid complexes can maintain antitumour pressure, reprogramme gene expression in multiple organs and offer long-term protection against cancer progression.

Protein-Lipid Complexes in Cancer Cell Death publication trend

The graph below shows the total number of articles in protein-lipid complexes in cancer cell death across all publications each year (not limited to Nature Index journals).

Technical terms

α-lactalbumin: a small calcium-binding milk protein that adopts a molten-globule state when complexed with fatty acids and mediates selective tumour cell death.

oleic acid: a monounsaturated fatty acid that drives membrane disruption and apoptotic signalling when delivered to cancer cells in complex form.

BAMLET/HAMLET: acronyms for bovine/human α-lactalbumin made lethal to tumour cells by non-covalent association with oleic acid.

apoptosis: programmed cell death characterised by caspase activation, DNA fragmentation and membrane blebbing.

Wnt/β-catenin signalling: a pathway regulating cellular proliferation and differentiation, frequently hyperactivated in colorectal cancer.

PD-1 pathway: an immune checkpoint signalling axis exploited by tumour cells to inhibit cytotoxic T-cell activity.

References

1. Ceruloplasmin Reduces the Lactoferrin/Oleic Acid Antitumor Complex-Mediated Release of Heme-Containing Proteins from Blood Cells. International Journal of Molecular Sciences (2023).
2. BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health. Scientific Reports (2024).
3. Molecular Characterization of α–Lactalbumin Folding Variants That Induce Apoptosis in Tumor Cells*. Journal of Biological Chemistry (1999).
4. The cytotoxicity of BAMLET complexes is due to oleic acid and independent of the α‐lactalbumin component. FEBS Open Bio (2015).